I have recently become Lead for Business Promotion and Social Media at HDI, having previously managed the National Audit of Breast Cancer in Older Patients (NABCOP). I have worked on cancer audit and research for over 20 years.
Outside work, when not ferrying my children to their various activities, I enjoy netball and yoga, walking our retired greyhounds, and going to the theatre or to watch live comedy.
Lead for Business Promotion and Social Media
Karen studied Psychology at the University of Birmingham. She joined the NHS in 2002 and has worked on cancer audits and research ever since. During this time her varied responsibilities have included project management, data collection and analyses, establishing funding sources and managing contracts, information and clinical governance, and more recently molecular research.
She has worked with a wide range of stakeholders across the health, academic and charity sectors and disseminated findings of these collaborative projects through publications, presentations and promotional activities. She is currently working on a PhD by Published Work.
Karen worked with HDI on the National Audit of Breast Cancer in Older Patients from 2017 to 2022. She is happy to be back to promote the excellent work of the HDI team and to increase awareness of the value of utilising health data for the benefit of patients and clinicians.
Education and awards
- APM Project Management Qualification, Association for Project Management
- AgilePM Foundation Award, APMG International
- Postgraduate Award in Techniques and Applications of Molecular Biology, University of Warwick
- Postgraduate Award in Clinical Oncology, University of Warwick
BSc Hons Psychology, University of Birmingham
Publications from the last 3 years:
Gannon MR, Dodwell D, Miller K, Horgan K, Clements K, Medina J, et al. Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data, Cancer Epidemiology, Volume 86, 2023 https://doi.org/10.1016/j.canep.2023.102423
Gannon MR, Dodwell D, Aggarwal A, Park MH, Miller K, Horgan K, et al. Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England. Br J Cancer 2023. https://doi.org/10.1038/s41416-023-02439-z
Miller K, Gannon MR, Medina J, Clements K, Dodwell D, Horgan K, et al. Variation in Rates of Post-Mastectomy Radiotherapy Among Women with Early Invasive Breast Cancer in England and Wales: A Population-Based Cohort Study. Clinical Oncology, Volume 35, Issue 9, e549 – e560, 2023. https://doi.org/10.1016/j.clon.2023.05.016
Clements K, Dodwell D, Hilton B, Stevens-Harris I, Pinder S, Wallis MG, et al. Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia. BMJ Open 2022;12: e061585. http://dx.doi.org/10.1136/bmjopen-2022-061585corr1
Shaaban AM, Hilton B, Clements K, Dodwell D, Sharma N, Kirwan C, et al. The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project. Br J Cancer 127, 2125–2132, 2022. https://doi.org/10.1038/s41416-022-01983-4
Maxwell AJ, Hilton B, Clements K, Dodwell D, Dulson-Cox J, Kearins O, et al. Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study. The Breast Volume 61, P145-155, 2022. https://doi.org/10.1016/j.breast.2022.01.001
Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, et al. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nat Genet 54, 850–860, 2022. https://doi.org/10.1038/s41588-022-01082-3
Jenkinson D, Freeman K, Clements K, Hilton B, Dulson-Cox J, Kearins O, et al. Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study). BMJ Open 2022;12: e058050. https://doi.org/10.1136/bmjopen-2021-058050
Jauhari Y, Gannon MR, Dodwell D, Horgan K, Clements K, Medina J, et al. Surgical decisions in older women with early breast cancer: patient and disease factors, British Journal of Surgery, Volume 108, Issue 2, February 2021, Pages 160–167. https://doi.org/10.1093/bjs/znaa042
Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S, Wallis MG, et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project. Br J Cancer 2021; 124:1009–17; https://doi.org/10.1038/s41416-020-01152-5
The National Audit of Breast Cancer in Older Patients